Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 40Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 31Lymphoma 29Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma, Mantle-Cell 25Lymphoma, Follicular 25Lymphoma, Non-Hodgkin 24Leukemia, Myeloid, Chronic-Phase 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myeloid, Accelerated Phase 22Lymphoma, Large B-Cell, Diffuse 21Hodgkin Disease 21Burkitt Lymphoma 21Anemia, Refractory, with Excess of Blasts 21Multiple Myeloma 20Myeloproliferative Disorders 17Lymphoma, Large-Cell, Immunoblastic 17Congenital Abnormalities 17Blast Crisis 17Dendritic Cell Sarcoma, Interdigitating 16Anemia, Refractory 15Recurrence 14Neoplasms, Plasma Cell 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Primary Myelofibrosis 12Leukemia, Biphenotypic, Acute 12Myelodysplastic-Myeloproliferative Diseases 11

Interventions

Cyclophosphamide 30N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 21Prednisone 20Etoposide 20Vincristine 16Whole-Body Irradiation 15Doxorubicin 15fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 14romidepsin 13Mycophenolic Acid 12Lenalidomide 12Gemcitabine 12Cyclosporine 10Azacitidine 10Brentuximab Vedotin 9Bortezomib 9Alemtuzumab 8Dexamethasone 7Methotrexate 6Cytarabine 6Busulfan 6Carmustine 5pembrolizumab 4fludarabine 4Vorinostat 4Tacrolimus 4Rituximab 4Melphalan 4Ifosfamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, T-Cell, Peripheral × Cord Blood Stem Cell Transplantation × Clear all
NCT01652014 2016-07-14

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡